Home/Tag: osteoporosis

Clinical Trial Targeting Lung Cancer, Plus Promising Osteoporosis and Incontinence Research get Support from Stem Cell Agency

The five-year survival rate for people diagnosed with the most advanced stage of non-small cell lung cancer (NSCLC) is between one and 10 percent. To address this devastating condition, the Board of the California Institute for Regenerative Medicine (CIRM) today voted to invest almost $12 million in a team from UCLA that is pioneering a

Bare bones: Making bones transparent

April 26, 2017 (Nanowerk News) Ten years ago, the bones currently in your body did not actually exist. Like skin, bone is constantly renewing itself, shedding old tissue and growing it anew from stem cells in the bone marrow. Now, a new technique developed at Caltech can render intact bones transparent, allowing researchers to observe

UC Davis licenses novel compound that helps stem cells regenerate bone to treat bone diseases

March 3, 2017 Hybrid molecule LLP2A-Alendronate could have implications for osteonecrosis, fractures, osteoporosis and inflammatory arthritis. The University of California, Davis, is pleased to announce a licensing agreement with Regenerative Arthritis and Bone Medicine, Inc. (RABOME) for a class of drugs developed at UC Davis that hold potential for treating diseases associated with bone loss

Watching stem cells change provides clues to fighting osteoporosis in older women

Oct. 05, 2016 by Jeff Sossamon COLUMBIA, Mo. – For years, scientists have studied how stem cells might be used to treat many diseases, including osteoporosis. One consistent challenge has been observing and monitoring the process through which stem cells transform. Now, using an established scientific method, University of Missouri researchers are able to watch

Study Shows How Stem Cells Might Restore Bones Damaged by Osteoporosis

A study recently published in STEM CELLS Translational Medicine points the way to a new, potentially restorative treatment for age-related or type II osteoporosis. Durham, NC (PRWEB) March 22, 2016 A study recently published in STEM CELLS Translational Medicine points the way to a new, potentially restorative treatment for age-related or type II osteoporosis. When

Exercise May Reverse Age-Related Bone Loss in Middle-Aged Men

Weight-lifting and jumping exercises improved bone density, could decrease osteoporosis risk July 14, 2015 - Story Contact:  Jesslyn ChewCOLUMBIA, Mo. – Men gradually lose bone mass as they age, which puts them at risk for developing osteoporosis, a condition that makes bones weak and prone to breakage. Nearly 2 million men in the U.S. have the

Research With Space Explorers May One Day Heal Earth’s Warriors

by Jessica Swann, Space Daily, Houston TX (SPX) Feb 19, 2015 NASA's Rodent Habitat module with both access doors open. Image courtesy NASA/Dominic Hart. For a larger version of this image please go here. Growing bone on demand sounds like a space-age concept-a potentially life changing one. Such a capability could benefit those needing bone for

Discovery may lead to new drugs for osteoporosis

Washington University in St. Louis, by Jim Dreyden ~ January 30, 2014 Scientists at Washington University School of Medicine in St. Louis have discovered what appears to be a potent stimulator of new bone growth. The finding could lead to new treatments for osteoporosis and other diseases that occur when the body doesn’t make enough

Elephant shark genome decoded ~ New insights gained into bone formation and immunity

Washington University in St. Louis, by Caroline Arbanas ~ January 8, 2014 An international team of researchers has sequenced the genome of the elephant shark, a curious-looking fish with a snout that resembles the end of an elephant’s trunk. The elephant shark and its cousins the sharks, rays, skates and chimaeras are the world’s oldest-living


By Julia Evangelou Strait Feb. 12, 2013 - Cancer drugs should kill tumors, not encourage their spread. But new evidence suggests that an emerging class of drugs may actually increase the risk of tumors spreading to bone, according to researchers at Washington University School of Medicine and the Siteman Cancer Center. The drugs, IAP antagonists,